Abstract
Skin cancer is the most commonly diagnosed type of all cancers (Gordon 2013; Siegel et al. 2018). Melanoma accounts for only 1% of skin cancer cases; however, it is considered the most lethal type of skin cancer (cancer.org 2018a). Cases of melanoma have increased in the past 30 years, and the lack of treatment has remained a challenge. Melanoma derives its name from the pigmented skin cells known as melanocytes, which are the source of its origin. Melanoma is also referred to as malignant melanoma or cutaneous melanoma (Miller and Mihm 2006). While melanocytes are pigmented, melanoma cells could be both pigmented, appearing black or brown, or unpigmented, pink or white, predominantly due to the ability or inability of the cells to synthesize melanin, respectively. Higher levels of melanin pigment in skin lowers the risk of developing melanoma; however, skin portions that lack pigmentation are still at risk of melanoma (cancer.org 2018b). Consequently to this inverse relationship of melanin and susceptibility of acquiring melanoma; proportion of melanoma patients are higher in Caucasians compared with African or Hispanic (Siegel et al. 2018).
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Barrallo-Gimeno, A., & Nieto, M. A. (2005). The Snail genes as inducers of cell movement and survival: Implications in development and cancer. Development (Cambridge, England), 132, 3151–3161.
Bian, D., Shi, W., Shao, Y., Li, P., & Song, G. (2017). Long non-coding RNA GAS5 inhibits tumorigenesis via miR-137 in melanoma. American Journal of Translational Research, 9, 1509–1520.
Cai, B., Zheng, Y., Ma, S., Xing, Q., Wang, X., Yang, B., Yin, G., & Guan, F. (2017). BANCR contributes to the growth and invasion of melanoma by functioning as a competing endogenous RNA to upregulate Notch2 expression by sponging miR204. International Journal of Oncology, 51, 1941–1951.
cancer.org. (2018a). Key statistics for melanoma skin cancer. Atlanta: American Cancer Society.
cancer.org. (2018b). What is melanoma skin cancer? Atlanta: American Cancer Society.
Cargnello, M., & Roux, P. P. (2011). Activation and function of the MAPKs and their substrates, the MAPK-activated protein kinases. Microbiology and Molecular Biology Reviews: MMBR, 75, 50–83.
Chen, L., Yang, H., Xiao, Y., Tang, X., Li, Y., Han, Q., Fu, J., Yang, Y., & Zhu, Y. (2016a). Lentiviral-mediated overexpression of long non-coding RNA GAS5 reduces invasion by mediating MMP2 expression and activity in human melanoma cells. International Journal of Oncology, 48, 1509–1518.
Chen, L., Yang, H., Xiao, Y., Tang, X., Li, Y., Han, Q., Fu, J., Yang, Y., & Zhu, Y. (2016b). LncRNA GAS5 is a critical regulator of metastasis phenotype of melanoma cells and inhibits tumor growth in vivo. OncoTargets and Therapy, 9, 4075–4087.
Chen, X., Dong, H., Liu, S., Yu, L., Yan, D., Yao, X., Sun, W., Han, D., & Gao, G. (2017a). Long noncoding RNA MHENCR promotes melanoma progression via regulating miR-425/489-mediated PI3K-Akt pathway. American Journal of Translational Research, 9, 90–102.
Chen, X., Liu, S., Zhao, X., Ma, X., Gao, G., Yu, L., Yan, D., Dong, H., & Sun, W. (2017b). Long noncoding RNA ILF3-AS1 promotes cell proliferation, migration, and invasion via negatively regulating miR-200b/a/429 in melanoma. Bioscience Reports, 37, BSR20171031.
Davies, H., Bignell, G. R., Cox, C., Stephens, P., Edkins, S., Clegg, S., Teague, J., Woffendin, H., Garnett, M. J., Bottomley, W., et al. (2002). Mutations of the BRAF gene in human cancer. Nature, 417, 949–954.
Dunn, J., Watson, M., Aitken, J. F., & Hyde, M. K. (2017). Systematic review of psychosocial outcomes for patients with advanced melanoma. Psycho-Oncology, 26, 1722–1731.
Egawa, N., Koshikawa, N., Tomari, T., Nabeshima, K., Isobe, T., & Seiki, M. (2006). Membrane type 1 matrix metalloproteinase (MT1-MMP/MMP-14) cleaves and releases a 22-kDa extracellular matrix metalloproteinase inducer (EMMPRIN) fragment from tumor cells. The Journal of Biological Chemistry, 281, 37576–37585.
Flockhart, R. J., Webster, D. E., Qu, K., Mascarenhas, N., Kovalski, J., Kretz, M., & Khavari, P. A. (2012). BRAFV600E remodels the melanocyte transcriptome and induces BANCR to regulate melanoma cell migration. Genome Research, 22, 1006–1014.
Goedert, L., Pereira, C. G., Roszik, J., Placa, J. R., Cardoso, C., Chen, G., Deng, W., Yennu-Nanda, V. G., Silva, W. A., Jr., Davies, M. A., et al. (2016). RMEL3, a novel BRAFV600E-associated long noncoding RNA, is required for MAPK and PI3K signaling in melanoma. Oncotarget, 7, 36711–36718.
Gordon, R. (2013). Skin cancer: An overview of epidemiology and risk factors. Seminars in Oncology Nursing, 29, 160–169.
Grant, G. D., Brooks, L., 3rd, Zhang, X., Mahoney, J. M., Martyanov, V., Wood, T. A., Sherlock, G., Cheng, C., & Whitfield, M. L. (2013). Identification of cell cycle-regulated genes periodically expressed in U2OS cells and their regulation by FOXM1 and E2F transcription factors. Molecular Biology of the Cell, 24, 3634–3650.
Gropler, M. C., Harris, T. E., Hall, A. M., Wolins, N. E., Gross, R. W., Han, X., Chen, Z., & Finck, B. N. (2009). Lipin 2 is a liver-enriched phosphatidate phosphohydrolase enzyme that is dynamically regulated by fasting and obesity in mice. The Journal of Biological Chemistry, 284, 6763–6772.
Guo, B., Zhang, Q., Wang, H., Chang, P., & Tao, K. (2018). KCNQ1OT1 promotes melanoma growth and metastasis. Aging, 10, 632–644.
Gupta, R. A., Shah, N., Wang, K. C., Kim, J., Horlings, H. M., Wong, D. J., Tsai, M. C., Hung, T., Argani, P., Rinn, J. L., et al. (2010). Long non-coding RNA HOTAIR reprograms chromatin state to promote cancer metastasis. Nature, 464, 1071–1076.
Hulstaert, E., Brochez, L., Volders, P. J., Vandesompele, J., & Mestdagh, P. (2017). Long non-coding RNAs in cutaneous melanoma: Clinical perspectives. Oncotarget, 8, 43470–43480.
Kawada, K., Sonoshita, M., Sakashita, H., Takabayashi, A., Yamaoka, Y., Manabe, T., Inaba, K., Minato, N., Oshima, M., & Taketo, M. M. (2004). Pivotal role of CXCR3 in melanoma cell metastasis to lymph nodes. Cancer Research, 64, 4010–4017.
Khaitan, D., Dinger, M. E., Mazar, J., Crawford, J., Smith, M. A., Mattick, J. S., & Perera, R. J. (2011). The melanoma-upregulated long noncoding RNA SPRY4-IT1 modulates apoptosis and invasion. Cancer Research, 71, 3852–3862.
Lee, S., Kopp, F., Chang, T. C., Sataluri, A., Chen, B., Sivakumar, S., Yu, H., Xie, Y., & Mendell, J. T. (2016). Noncoding RNA NORAD regulates genomic stability by sequestering PUMILIO proteins. Cell, 164, 69–80.
Lee, B., Sahoo, A., Marchica, J., Holzhauser, E., Chen, X., Li, J. L., Seki, T., Govindarajan, S. S., Markey, F. B., Batish, M., et al. (2017). The long noncoding RNA SPRIGHTLY acts as an intranuclear organizing hub for pre-mRNA molecules. Science Advances, 3, e1602505.
Lessard, L., Liu, M., Marzese, D. M., Wang, H., Chong, K., Kawas, N., Donovan, N. C., Kiyohara, E., Hsu, S., Nelson, N., et al. (2015). The CASC15 long intergenic noncoding RNA locus is involved in melanoma progression and phenotype switching. The Journal of Investigative Dermatology, 135, 2464–2474.
Leucci, E., Vendramin, R., Spinazzi, M., Laurette, P., Fiers, M., Wouters, J., Radaelli, E., Eyckerman, S., Leonelli, C., Vanderheyden, K., et al. (2016a). Melanoma addiction to the long non-coding RNA SAMMSON. Nature, 531, 518–522.
Leucci, E., Coe, E. A., Marine, J. C., & Vance, K. W. (2016b). The emerging role of long non-coding RNAs in cutaneous melanoma. Pigment Cell and Melanoma Research, 29, 619–626.
Li, R., Zhang, L., Jia, L., Duan, Y., Li, Y., Bao, L., & Sha, N. (2014). Long non-coding RNA BANCR promotes proliferation in malignant melanoma by regulating MAPK pathway activation. PLoS One, 9, e100893.
Li, P., Gao, Y., Li, J., Zhou, Y., Yuan, J., Guan, H., & Yao, P. (2018). LncRNA MEG3 repressed malignant melanoma progression via inactivating Wnt signaling pathway. Journal of Cellular Biochemistry, 119(9), 7498–7505.
Liao, Z., Zhao, J., & Yang, Y. (2018). Downregulation of lncRNA H19 inhibits the migration and invasion of melanoma cells by inactivating the NFkappaB and PI3K/Akt signaling pathways. Molecular Medicine Reports, 17, 7313–7318.
Long, J., & Pi, X. (2018). lncRNA-MEG3 suppresses the proliferation and invasion of melanoma by regulating CYLD expression mediated by sponging miR-499-5p. BioMed Research International, 2018, 2086564.
Long, J., Menggen, Q., Wuren, Q., Shi, Q., & Pi, X. (2018). Long noncoding RNA taurine-upregulated gene1 (TUG1) promotes tumor growth and metastasis through TUG1/Mir-129-5p/astrocyte-elevated gene-1 (AEG-1) axis in malignant melanoma. Medical Science Monitor: International Medical Journal of Experimental and Clinical Research, 24, 1547–1559.
Luan, W., Li, L., Shi, Y., Bu, X., Xia, Y., Wang, J., Djangmah, H. S., Liu, X., You, Y., & Xu, B. (2016). Long non-coding RNA MALAT1 acts as a competing endogenous RNA to promote malignant melanoma growth and metastasis by sponging miR-22. Oncotarget, 7, 63901–63912.
Luan, W., Li, R., Liu, L., Ni, X., Shi, Y., Xia, Y., Wang, J., Lu, F., & Xu, B. (2017). Long non-coding RNA HOTAIR acts as a competing endogenous RNA to promote malignant melanoma progression by sponging miR-152-3p. Oncotarget, 8, 85401–85414.
Luan, W., Zhou, Z., Ni, X., Xia, Y., Wang, J., Yan, Y., & Xu, B. (2018). Long non-coding RNA H19 promotes glucose metabolism and cell growth in malignant melanoma via miR-106a-5p/E2F3 axis. Journal of Cancer Research and Clinical Oncology, 144, 531–542.
Lv, L., Jia, J. Q., & Chen, J. (2018). The lncRNA CCAT1 upregulates proliferation and invasion in melanoma cells via suppressing miR-33a. Oncology Research, 26, 201–208.
Mazar, J., Zhao, W., Khalil, A. M., Lee, B., Shelley, J., Govindarajan, S. S., Yamamoto, F., Ratnam, M., Aftab, M. N., Collins, S., et al. (2014). The functional characterization of long noncoding RNA SPRY4-IT1 in human melanoma cells. Oncotarget, 5, 8959–8969.
Miller, A. J., & Mihm, M. C., Jr. (2006). Melanoma. The New England Journal of Medicine, 355, 51–65.
Miller, K. D., Siegel, R. L., Lin, C. C., Mariotto, A. B., Kramer, J. L., Rowland, J. H., Stein, K. D., Alteri, R., & Jemal, A. (2016). Cancer treatment and survivorship statistics, 2016. CA: A Cancer Journal for Clinicians, 66, 271–289.
Mou, K., Liu, B., Ding, M., Mu, X., Han, D., Zhou, Y., & Wang, L. J. (2018). lncRNA-ATB functions as a competing endogenous RNA to promote YAP1 by sponging miR-590-5p in malignant melanoma. International Journal of Oncology, 53(3), 1094–1104.
Ni, N., Song, H., Wang, X., Xu, X., Jiang, Y., & Sun, J. (2017). Up-regulation of long noncoding RNA FALEC predicts poor prognosis and promotes melanoma cell proliferation through epigenetically silencing p21. Biomedicine and Pharmacotherapy, 96, 1371–1379.
Pasmant, E., Laurendeau, I., Heron, D., Vidaud, M., Vidaud, D., & Bieche, I. (2007). Characterization of a germ-line deletion, including the entire INK4/ARF locus, in a melanoma-neural system tumor family: Identification of ANRIL, an antisense noncoding RNA whose expression coclusters with ARF. Cancer Research, 67, 3963–3969.
Poliseno, L., Haimovic, A., Christos, P. J., Vega, Y. S. d. M. E. C., Shapiro, R., Pavlick, A., Berman, R. S., Darvishian, F., & Osman, I. (2011). Deletion of PTENP1 pseudogene in human melanoma. The Journal of Investigative Dermatology, 131, 2497–2500.
Pullen, T. J., & Rutter, G. A. (2014). Roles of lncRNAs in pancreatic beta cell identity and diabetes susceptibility. Frontiers in Genetics, 5, 193.
Richtig, G., Hoeller, C., Kashofer, K., Aigelsreiter, A., Heinemann, A., Kwong, L. N., Pichler, M., & Richtig, E. (2017a). Beyond the BRAF(V)(600E) hotspot: Biology and clinical implications of rare BRAF gene mutations in melanoma patients. The British Journal of Dermatology, 177, 936–944.
Richtig, G., Ehall, B., Richtig, E., Aigelsreiter, A., Gutschner, T., & Pichler, M. (2017b). Function and clinical implications of long non-coding RNAS in melanoma. International Journal of Molecular Sciences, 18, 715.
Rubinstein, J. C., Sznol, M., Pavlick, A. C., Ariyan, S., Cheng, E., Bacchiocchi, A., Kluger, H. M., Narayan, D., & Halaban, R. (2010). Incidence of the V600K mutation among melanoma patients with BRAF mutations, and potential therapeutic response to the specific BRAF inhibitor PLX4032. Journal of Translational Medicine, 8, 67.
Sanchez Calle, A., Kawamura, Y., Yamamoto, Y., Takeshita, F., & Ochiya, T. (2018). Emerging roles of long non-coding RNA in cancer. Cancer Science, 109, 2093–2100.
Sandru, A., Voinea, S., Panaitescu, E., & Blidaru, A. (2014). Survival rates of patients with metastatic malignant melanoma. Journal of Medicine and Life, 7, 572–576.
Sanlorenzo, M., Vujic, I., Esteve-Puig, R., Lai, K., Vujic, M., Lin, K., Posch, C., Dimon, M., Moy, A., Zekhtser, M., et al. (2018). The lincRNA MIRAT binds to IQGAP1 and modulates the MAPK pathway in NRAS mutant melanoma. Scientific Reports, 8, 10902.
Schmidt, K., Joyce, C. E., Buquicchio, F., Brown, A., Ritz, J., Distel, R. J., Yoon, C. H., & Novina, C. D. (2016). The lncRNA SLNCR1 mediates melanoma invasion through a conserved SRA1-like region. Cell Reports, 15, 2025–2037.
Schmitt, A. M., & Chang, H. Y. (2016). Long noncoding RNAs in cancer pathways. Cancer Cell, 29, 452–463.
Siegel, R. L., Miller, K. D., & Jemal, A. (2018). Cancer statistics, 2018. CA: A Cancer Journal for Clinicians, 68, 7–30.
Singh, D., Srivastava, S. K., Chaudhuri, T. K., & Upadhyay, G. (2015). Multifaceted role of matrix metalloproteinases (MMPs). Frontiers in Molecular Biosciences, 2, 19.
Song, X., Sun, Y., & Garen, A. (2005). Roles of PSF protein and VL30 RNA in reversible gene regulation. Proceedings of the National Academy of Sciences of the United States of America, 102, 12189–12193.
Sousa, J. F., Torrieri, R., Silva, R. R., Pereira, C. G., Valente, V., Torrieri, E., Peronni, K. C., Martins, W., Muto, N., Francisco, G., et al. (2010). Novel primate-specific genes, RMEL 1, 2 and 3, with highly restricted expression in melanoma, assessed by new data mining tool. PLoS One, 5, e13510.
Sun, Y., Cheng, H., Wang, G., Yu, G., Zhang, D., Wang, Y., Fan, W., & Yang, W. (2017). Deregulation of miR-183 promotes melanoma development via lncRNA MALAT1 regulation and ITGB1 signal activation. Oncotarget, 8, 3509–3518.
Tang, L., Zhang, W., Su, B., & Yu, B. (2013). Long noncoding RNA HOTAIR is associated with motility, invasion, and metastatic potential of metastatic melanoma. BioMed Research International, 2013, 251098.
Tian, Y., Zhang, X., Hao, Y., Fang, Z., & He, Y. (2014). Potential roles of abnormally expressed long noncoding RNA UCA1 and Malat-1 in metastasis of melanoma. Melanoma Research, 24, 335–341.
Uzdensky, A. B., Demyanenko, S. V., & Bibov, M. Y. (2013). Signal transduction in human cutaneous melanoma and target drugs. Current Cancer Drug Targets, 13, 843–866.
Valdearcos, M., Esquinas, E., Meana, C., Pena, L., Gil-de-Gomez, L., Balsinde, J., & Balboa, M. A. (2012). Lipin-2 reduces proinflammatory signaling induced by saturated fatty acids in macrophages. The Journal of Biological Chemistry, 287, 10894–10904.
Wang, Y., Chen, W., Yang, C., Wu, W., Wu, S., Qin, X., & Li, X. (2012). Long non-coding RNA UCA1a(CUDR) promotes proliferation and tumorigenesis of bladder cancer. International Journal of Oncology, 41, 276–284.
Wang, Z., Wang, X., Zhou, H., Dan, X., Jiang, L., & Wu, Y. (2018). Long non-coding RNA CASC2 inhibits tumorigenesis via the miR-181a/PLXNC1 axis in melanoma. Acta Biochimica et Biophysica Sinica, 50, 263–272.
Wei, Y., Sun, Q., Zhao, L., Wu, J., Chen, X., Wang, Y., Zang, W., & Zhao, G. (2016). LncRNA UCA1-miR-507-FOXM1 axis is involved in cell proliferation, invasion and G0/G1 cell cycle arrest in melanoma. Medical Oncology (Northwood, London, England), 33, 88.
Wu, L., Murat, P., Matak-Vinkovic, D., Murrell, A., & Balasubramanian, S. (2013a). Binding interactions between long noncoding RNA HOTAIR and PRC2 proteins. Biochemistry, 52, 9519–9527.
Wu, C. F., Tan, G. H., Ma, C. C., & Li, L. (2013b). The non-coding RNA llme23 drives the malignant property of human melanoma cells. Journal of Genetics and Genomics, 40, 179–188.
Xu, S., Wang, H., Pan, H., Shi, Y., Li, T., Ge, S., Jia, R., Zhang, H., & Fan, X. (2016). ANRIL lncRNA triggers efficient therapeutic efficacy by reprogramming the aberrant INK4-hub in melanoma. Cancer Letters, 381, 41–48.
Yan, L., Wang, S., Li, Y., Tognetti, L., Tan, R., Zeng, K., Pianigiani, E., Mi, X., Li, H., Fimiani, M., et al. (2018). SNHG5 promotes proliferation and induces apoptosis in melanoma by sponging miR-155. RSC Advances, 8, 6160–6168.
Yap, K. L., Li, S., Munoz-Cabello, A. M., Raguz, S., Zeng, L., Mujtaba, S., Gil, J., Walsh, M. J., & Zhou, M. M. (2010). Molecular interplay of the noncoding RNA ANRIL and methylated histone H3 lysine 27 by polycomb CBX7 in transcriptional silencing of INK4a. Molecular Cell, 38, 662–674.
Yin, Y., Zhao, B., Li, D., & Yin, G. (2018). Long non-coding RNA CASC15 promotes melanoma progression by epigenetically regulating PDCD4. Cell & Bioscience, 8, 42.
Zhang, H., Bai, M., Zeng, A., Si, L., Yu, N., & Wang, X. (2017). LncRNA HOXD-AS1 promotes melanoma cell proliferation and invasion by suppressing RUNX3 expression. American Journal of Cancer Research, 7, 2526–2535.
Zhao, W., Mazar, J., Lee, B., Sawada, J., Li, J. L., Shelley, J., Govindarajan, S., Towler, D., Mattick, J. S., Komatsu, M., et al. (2016). The Long noncoding RNA SPRIGHTLY regulates cell proliferation in primary human melanocytes. The Journal of Investigative Dermatology, 136, 819–828.
Zhao, H., Xing, G., Wang, Y., Luo, Z., Liu, G., & Meng, H. (2017). Long noncoding RNA HEIH promotes melanoma cell proliferation, migration and invasion via inhibition of miR-200b/a/429. Bioscience Reports, 37, BSR20170682.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Joshi, P., Perera, R.J. (2019). The Role of Long Non-coding RNAs in Melanoma Genesis and Progression. In: Khalil, A. (eds) Molecular Biology of Long Non-coding RNAs. Springer, Cham. https://doi.org/10.1007/978-3-030-17086-8_5
Download citation
DOI: https://doi.org/10.1007/978-3-030-17086-8_5
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-17085-1
Online ISBN: 978-3-030-17086-8
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)